Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-5-20
|
pubmed:abstractText |
Serotherapy, an approach currently used to protect humans against animal bites or stings, is often too specific. To broaden antiserum paraspecificity, use of antibodies directed against areas shared by all members of a toxin family was previously proposed. MST2 is a mAb that recognizes all long-chain curaremimetic toxins (Charpentier et al. (1990) J. Mol. Recog. 3, 74-81). It binds to toxin residues that make contact with the toxin's target, e.g., the nicotinic acetylcholine receptor (AcChoR). We now show that MST2 also recognizes (-) nicotine, an agonist of AcChoR. Binding properties of MST2 therefore mimick, at least partially, binding properties of AcChoR. Injection in rabbits of MST2 mixed with adjuvant, elicited anti-idiotypic (anti-Id) antibodies that inhibited binding of the toxin to AcChoR. A proportion of these anti-Id antibodies specifically bound AcChoR and thereby mimicked the toxin. Furthermore, rabbits immunized with MST2 elicited auto-anti-anti-Id antibodies capable of binding the toxin. Our data provide a molecular explanation for the previously reported signs of myasthenia gravis as triggered by antibodies raised against cholinergic antagonists. Implications in the design of antisera to toxic proteins are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anti-Idiotypic,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Cobra Neurotoxin Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neuromuscular Nondepolarizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Nicotine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cholinergic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
1138
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
282-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1532909-Animals,
pubmed-meshheading:1532909-Antibodies, Anti-Idiotypic,
pubmed-meshheading:1532909-Antibodies, Monoclonal,
pubmed-meshheading:1532909-Autoimmune Diseases,
pubmed-meshheading:1532909-Binding Sites,
pubmed-meshheading:1532909-Cobra Neurotoxin Proteins,
pubmed-meshheading:1532909-Immunization,
pubmed-meshheading:1532909-Myasthenia Gravis,
pubmed-meshheading:1532909-Neuromuscular Nondepolarizing Agents,
pubmed-meshheading:1532909-Nicotine,
pubmed-meshheading:1532909-Protein Conformation,
pubmed-meshheading:1532909-Rabbits,
pubmed-meshheading:1532909-Receptors, Cholinergic
|
pubmed:year |
1992
|
pubmed:articleTitle |
Anti-idiotypic and anti-anti-idiotypic responses to a monoclonal antibody directed to the acetylcholine receptor binding site of curaremimetic toxins.
|
pubmed:affiliation |
Département d'Ingenierie et d'Etudes des Protéines CE Saclay, Gif-sur-Yvette, France.
|
pubmed:publicationType |
Journal Article
|